18 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
clinical trials and upon any commercialization of any product candidates. Inadequate training in recognizing or managing the potential side effects … and to prevent security breaches, including costs related to deploying additional personnel and protection technologies, training employees, and engaging
DEF 14A
PNT
POINT Biopharma Global Inc.
28 Apr 22
Definitive proxy
8:36am
degree from the University of Toronto in 1988. He completed specialty training in urologic surgery and oncology from 1993 to 1996, received a Master’s … in Public Health in epidemiology from Columbia University in 1997, and completed his oncology training at Memorial Sloan-Kettering Cancer Center. Dr
424B3
pm6ji mvzopsyf
31 Mar 22
Prospectus supplement
11:42am
POS AM
1a7d7m154r dka8
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
7r5huhp
5 Aug 21
Prospectus supplement
4:26pm
424B3
qjah6
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.18
8ssz8 warj5cirb0
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
97mqw3 uy
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
nk9rtu9xmlgcc905g
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.18
9btifyoj lahcmu
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
oe3kr0
18 Mar 21
Financial Statements and Exhibits
9:08am
- Prev
- 1
- Next